- Published at
- by seekingalpha.com
neutral
neutral
Alterity Therapeutics Ltd (ATHE) CEO David Stamler on Q2 2021 Results - Earnings Call Transcript
Alterity Therapeutics Ltd (NASDAQ:ATHE) Q2 2021 Earnings Conference Call February 25, 2021, 17:00 ET Company Participants David Stamler - CEO, Chief Medical Officer & SVP, Clinical...